Table 3. Prognostic factors for DFS and OS by univariate analysis.
| PVTT | |||||||||
| No | 250 | 51.6% | 35.2% | 31.4% | < 0.001 | 78.8% | 52.0% | 44.7% | < 0.001 |
| Yes | 53 | 11.3% | 9.4% | 7.5% | 35.8% | 18.9% | 11.0% | ||
| Tumor number | |||||||||
| Single | 215 | 53.5% | 38.1% | 33.9% | < 0.001 | 77.0% | 54.9% | 48.6% | < 0.001 |
| Multiple | 88 | 22.7% | 12.4% | 10.6% | 56.8% | 26.3% | 16.7% | ||
| Tumor size(cm) | |||||||||
| < 5 | 105 | 68.6% | 51.4% | 43.5% | < 0.001 | 88.6% | 68.6% | 60.0% | < 0.001 |
| ≥5 | 198 | 31.8% | 19.7% | 18.7% | 62.1% | 34.3% | 27.7% | ||
| Complication | |||||||||
| No | 258 | 44.6% | 32.2% | 28.1% | 0.424 | 72.5% | 46.5% | 40.2% | 0.361 |
| Yes | 45 | 44.4% | 22.2% | 22.2% | 64.4% | 44.4% | 30.8% | ||
| Tumor differentiation | |||||||||
| I-II | 235 | 48.5% | 34.0% | 30.5% | 0.003 | 73.6% | 48.9% | 42.9% | 0.006 |
| III-IV | 68 | 30.9% | 19.1% | 16.2% | 63.2% | 36.8% | 24.8% | ||
| Resection margin(cm) | |||||||||
| < 2 | 171 | 42.1% | 26.9% | 23.2% | 0.186 | 70.8% | 41.5% | 34.4% | 0.069 |
| ≥2 | 131 | 47.3% | 35.1% | 31.9% | 71.8% | 51.9% | 44.2% | ||
| Intraoperative blood loss(ml) | |||||||||
| ≤ 1000 | 237 | 48.9% | 34.6% | 31.0% | < 0.001 | 76.4% | 50.6% | 43.8% | < 0.001 |
| > 1000 | 66 | 28.8% | 16.7% | 13.6% | 53.0% | 30.3% | 21.0% | ||
| ANRI | |||||||||
| ≤ 7.8 | 92 | 59.8% | 46.7% | 43.3% | < 0.001 | 81.5% | 62.0% | 55.4% | < 0.001 |
| > 7.8 | 211 | 37.9% | 23.7% | 20.2% | 66.8% | 39.3% | 31.6% | ||
| NLR | |||||||||
| ≤ 2 | 223 | 48.9% | 35.9% | 31.7% | < 0.001 | 75.3% | 53.4% | 45.7% | < 0.001 |
| > 2 | 80 | 32.5% | 16.2% | 14.9% | 60.0% | 26.3% | 20.0% | ||
| APRI | |||||||||
| ≤ 1.68 | 104 | 57.7% | 41.3% | 38.3% | < 0.001 | 82.7% | 59.6% | 52.9% | < 0.001 |
| > 1.68 | 199 | 37.7% | 25.1% | 21.4% | 65.3% | 39.2% | 31.5% | ||
| PLR | |||||||||
| ≤ 115 | 173 | 50.3% | 35.8% | 30.5% | 0.025 | 75.7% | 35.0% | 45.6% | 0.005 |
| > 115 | 130 | 36.9% | 23.8% | 23.1% | 65.4% | 35.4% | 29.9% | ||
| ALRI | |||||||||
| ≤ 20 | 135 | 57.0% | 42.2% | 38.5% | < 0.001 | 81.5% | 60.7% | 54.1% | < 0.001 |
| > 20 | 168 | 34.5% | 21.4% | 18.0% | 63.1% | 34.5% | 26.5% | ||
PVTT: portal vein tumor thrombus; ANRI, Aspartate aminotransferase/neutrophil count ratio index; NLR: neutrophil/lymphocyte ratio index; APRI: aspartate aminotransferase/platelet count ratio index; PLR: platelet/lymphocyte ratio index; ALRI: aspartate aminotransferase/Lymphocyte count ratio index.